Body mass index can similarly predict the presence of multiple cardiovascular risk factors in middle-aged Japanese subjects as waist circumference

Internal Medicine

Volumn 49, Issue 11, 2010, Pages 977-982

  Satoh, Hiroki ^a   Kishi, Reiko ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Body mass index; Epidemiology; Middle aged Japanese subjects; Risk factor; Waist circumference

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 77953354639     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3006     Document Type: Article

References (30)

1. Oda E, Kawai R. Age- and gender-related differences in correlations between abdominal obesity and obesity-related metabolic risk factors in Japanese. Intern Med 48: 497-502, 2009.
2. Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 373: 1083-1096, 2009.
3. Sone H, Mizuno S, Fujii H, et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. Diabetes Care 28: 1463-1471, 2005.
4. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
5. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689, 2001.
6. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109: 433-438, 2004.
7. Huang KC, Lee MS, Lee SD, et al. Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan. Obes Res 13: 170-178, 2005.
8. Misra A, Madhavan M, Vikram NK, Pandey RM, Dhingra V, Lu-thra K. Simple anthropometric measures identify fasting hyperin-sulinemia and clustering of cardiovascular risk factors in Asian Indian adolescents. Metabolism 55: 1569-1573, 2006.
9. Thomas GN, Ho SY, Lam KS, Janus ED, Hedley AJ, Lam TH. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 12: 1805-1813, 2004.
10. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr 81: 409-415, 2005.
11. Farin HM, Abbasi F, Reaven GM. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 98: 1053-1056, 2006.
12. Pankow JS, Jacobs DR Jr, Steinberger J, Moran A, Sinaiko AR. Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care 27: 775-780, 2004
13. Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2: 105-112, 2005.
14. Klein S, Allison DB, Heymsfield SB, et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30: 1647-1652, 2007.
15. Lear SA, Humphries KH, Kohli S, Birmingham CL. The use of BMI and waist circumference as surrogates of body fat differs by ethnicity. Obesity (Silver Spring) 15: 2817-2824, 2007.
16. Matsuzawa Y. Metabolic syndrome-Definition and diagnostic criteria in Japan. J Jpn Soc Int Med 94: 188-203, 2005 (in Japanese).
17. Balkau B, Deanfield JE, Despres JP, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116: 1942-1951, 2007.
18. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 359: 2105-2120, 2008.
19. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738, 2000.
20. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am 33: 283-303, 2004.
21. Kashyap SR, Defronzo RA. The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 4: 13-19, 2007.
22. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res 6 (Suppl 2): 51S-209S, 1998.
23. World Health Organization: Obesity: Preventing and managing the global epidemic: Report of a WHO Consultation on Obesity. Geneva, World Health Organization 1998.
24. Shen W, Punyanitya M, Wang Z, et al. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97: 2333-2338, 2004.
25. World Health Organization Western Pacific Region, International Association for the Study of Obesity, International Obesity Task Force. The Asian-Pacific Perspective: Redefining Obesity and its Treatment. World Health Organization Pacific Region, Geneva, 2000.
26. Ishikawa-Takata K, Ohta T, Moritaki K, Gotou T, Inoue S. Obesity, weight change and risks for hypertension, diabetes and hyper-cholesterolemia in Japanese men. Eur J Clin Nutr 56: 601-607, 2002.
27. The Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study Obesity. New criteria for 'obesity disease' in Japan. Circ J 66: 987-992, 2002.
28. Miyawaki T, Hirata M, Moriyama K, et al. Metabolic syndrome in Japanese diagnosed with visceral fat measurement by computed tomography. Proc Japan Acad 81: 471-479, 2005.
29. Baik I. Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J 73: 2068-2075, 2009.
30. Takahashi M, Shimomura K, Proks P, et al. A proposal of combined evaluation of waist circumference and BMI for the diagnosis of metabolic syndrome. Endocr J 56: 1079-1082, 2009.